Navigation Links
UniCare Introduces Consumer-Driven Health Products to Give Consumers a Bigger Role in Health Care Decisions
Date:10/1/2007

Solaura(R) to provide the information and incentives needed to help improve

health

CHICAGO, Oct. 1 /PRNewswire/ -- UniCare is now offering Solaura, a new line of health care plans designed to change the way consumers think about health care, help them lead healthier lives and help reduce the cost of health care in the long term.

UniCare announced earlier this year that it would launch a new line of consumer-driven health plans (CDHP) that would be available to large and small businesses, as well as individuals. Solaura will be available effective October 1, 2007, pending regulatory approval in some states.

"Our customers who choose these consumer-driven products will have new opportunities to live healthier lives," said Dennis Casey, UniCare president and CEO. "Our Solaura suite of products puts consumers in control of their health care dollars."

UniCare will offer the following core CDHP products:

-- Solaura(R) Health Reimbursement Account (HRA)

-- Solaura(R) Health Savings Account (HSA)

-- Solaura(R) Health Incentive Account (HIA)

-- Solaura(R) Health Incentive Account Plus (HIA+)

Consumers who select Solaura products may also be eligible for extensive preventive care and personal health coaching, as well as smoking cessation and weight management programs. In addition, consumers may be eligible to receive financial rewards for completing various wellness programs.

"We're providing our consumers with information-rich web-based tools that they can use to research prescription drug prices and estimated costs of care," Casey said.

UniCare's CDHP options combine health accounts with traditional PPO health coverage. Each is backed by powerful online decision support tools and personal health coaching that consumers can use to learn more about their health care treatment and cost options.

For example, when members complete an online health assessment,
'/>"/>

SOURCE UniCare
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. TI Cycles Introduces Foldman
3. Canada Introduces Mandatory Nutrition Labeling
4. Amgen introduces Autoinjector For Treating Anemia
5. Cuba Introduces New Device for Detecting Vascular Diseases
6. China Introduces Solar-powered Baths
7. Allergan Introduces ‘Dermal Filler’ for Smile Lins
8. UAE Introduces Cervical Cancer Vaccine
9. Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation
10. Iceland Introduces Smoking Ban in Bars and Restaurants
11. Indian Introduces Paan-flavoured Condoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ed, "frozen lozenge" provides breakthrough method ..., Dec. 2 "A spoonful of sugar help... it just isn,t that easy. That,s why Insight Phar...e, frozen single-use packages that offer cooling, ...shest sore throats. , , Sucrets ICE is th...
(Date:12/2/2008)... For most people, family gatherings, ...he fun of the holiday season. Not so for those wit...d--social situations, reports the December 2008 is... Boston (Vocus) December 2, 2008 --...other social activities are part of the fun of the...
(Date:12/2/2008)...Dec. 2 EIN News has ann...g in-depth news on brain cancer. , , With n...e finding out that information is one of the key c...ding to the growing demand for accurate informatio...procedures and drugs to treat it, EIN News is intr...
(Date:12/2/2008)...orice, pancakes, among other products, home to sod...althDay News) -- There can be plenty of sodium -- ... health-friendly, and shoppers should know that lo...fat products. , That,s the finding of a report ...zine. , Researchers analyzed 37 common supermar...
Breaking Medicine News(10 mins):Health News:New Sucrets(R) ICE Cools Sore Throat Pain 2Health News:Easing Social Anxiety During the Holidays: Tips from Harvard Women's Health Watch 2Health News:EIN News Introduces 'Brain Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:High Salt Levels Common in Many Foods 2
... virtual reality simulation tools are making denti... if M. Cenk Cavusoglu has his // way, then this me...rform delicate surgeries in a risk-free manner. "...cause it reduces the learning time and allows stud...
...n Victoria have claimed that they have developed a...se two viruses in question can easily kill humans ...harge sheet against the viruses is that Hendra vir...minent Queensland racehorse trainer Vic Rail and 1...
...uncture, even sham acupuncture may be as effective...omparable level of treatment efficacy has been doc... results were obtained with respect to reduction i...with a diagnosis of migraine were included for the...
... Organization to investigate the possibility of bu...ks of bird flu//. They are already ready to invest... investigation with bird flu virus is already bein...ns in the House of Commons about the UK's prepared...
Other Medicine News:
(Date:11/28/2008)...ember 28 German biotech company,P...lized HIV monitoring and,AIDS patient follow-up d...In,the year 2008, 2.5 million patient tests have ...ly affordable "CyFlow" system, supporting already,...Due to introduction of the,Partec innovation, the...
(Date:11/26/2008)...ity, automation and intelligent clinical applicati...ll new level , , CHICAGO, Ill., Nov. 26 /PR...w.siemens.com/healthcare ) highlights the ACUSON ...), the world,s first multi-use, automated volume ...ssembly and Annual Meeting of the Radiological Soc...
(Date:11/25/2008)...dents against expanding statin use broadly in wake....J., Nov. 25 JUPITER, a clinical t...ascular risk of healthy patients with elevated CRP...adults, according to a national poll directed at h...part in the online poll conducted by medical news ...
(Date:11/25/2008)...linical Trial to Assess Survival of Patients Recei...resectable Hepatocellular Carcinoma , , BEL...es Oncology, Inc. (LSO) today announced the comple...ial of Light Infusion Therapy(TM) (Litx(TM)) as a ...a (HCC), also known as hepatoma or primary liver c...
Breaking Medicine Technology:German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Citizens Republic Bancorp Selects HealthPlus as Sole Provider of Health Insurance for 2009 30619 1Citizens Republic Bancorp Selects HealthPlus as Sole Provider of Health Insurance for 2009 30619 2Travis E Baugh Named President COO of HEALTHPOINT Ltd 30614 1Travis E Baugh Named President COO of HEALTHPOINT Ltd 30614 2Protein folding researcher David Baker to receive Sackler Prize in Biophysics 6038 1Protein folding researcher David Baker to receive Sackler Prize in Biophysics 6038 2Huntington Area Development Council Attracts Technology Based Startup Companies With 24150 000 Grant From Verizon West Virginia 9358 1Huntington Area Development Council Attracts Technology Based Startup Companies With 24150 000 Grant From Verizon West Virginia 9358 2
...h 12, 2007--Inflazyme,Pharmaceuticals Ltd. (TSX: I...nary results of the Phase 2b CAPSICS study with,IP...nce between,patients who received drug or placebo....rge and consistent across a number of,the end-poin... its,external experts to determine if anything unt...
...r BLA filing for C1-inhibitor,replacement therapy,...- Lev,Pharmaceuticals, Inc. (Lev) today announced ...rial of C1-esterase inhibitor (C1-INH),for the acu...e,acute study, which is part of the company,s CHAN...anofiltration Generation,evaluating Efficacy), the...
Other Medicine Technology:Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 2Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5
...feature-packed projectors ideal for any practice. ...for longer life -- up to 2,000 hours under typical...tial cost with an incandescent illumination system.... And both provide exceptionally even illumination...
...cal design and utilizes a multi-layered, multi-coa... producing a measurable 20% increase in optical re...lity of the Ultra Series also results in a 20% inc...of view and a 14% increase in depth of field. A si...
With the touch of a button, the Marco Encore Automatic Chair quickly reclines from an upright position to a fully horizontal, flat-table mode-or anywhere in between.
Both the Marco Keratometer I and Keratometer II are one position instruments for objectively measuring corneal curvature. The keratometer II has the added feature of internal readings for the presbyo
Medicine Products: